Cytek Biosciences saw the highest growth of 2.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Cytek Biosciences‘s patent filings and grants. Buy the databook here.
Cytek Biosciences has been focused on protecting inventions in United States(US) with eight publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 60% filings and 100% grants. The United States(US), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Cytek Biosciences is filings its patents. Among the top granted patent authorities, Cytek Biosciences has 100% of its grants in United States(US).
Becton Dickinson and Co and Danaher could be the strongest competitors for Cytek Biosciences
Patents related to industrial automation lead Cytek Biosciences's portfolio
Cytek Biosciences has the highest number of patents in industrial automation. For industrial automation, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Flow cytometers related patents lead Cytek Biosciences portfolio followed by image management
Cytek Biosciences has highest number of patents in flow cytometers followed by image management.
For comprehensive analysis of Cytek Biosciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.